Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Levobunolol Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Indications
Dosages
Interactions
Precautions
Contraindications
Adverse Reactions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Adrenaline

  • Adverse Effect Hypertension, bradycardia, resistance to Adrenaline in anaphylaxis
  • Clinical Management Concurrent use should be avoided if possible. However, if used concurrently, monitor blood pressure carefully. If Levobunolol causes resistance to Adrenaline in anaphylactic shock, glucagon may be effective in a dose of 1 mg or more intravenously every five minutes.

    Amiodarone

  • Adverse Effect hypotension, bradycardia, or cardiac arrest
  • Clinical Management Monitor cardiac function carefully. Amiodarone should be used with caution in patients receiving beta blockers particularly if there is suspicion of underlying dysfunction of the sinus node, such as bradycardia or sick sinus syndrome, or if there is partial AV block.

    Amlodipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Benidipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Celecoxib

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Clonidine

  • Adverse Effect exaggerated clonidine withdrawal response (acute hypertension)
  • Clinical Management Patients to be withdrawn from clonidine who are concomitantly receiving Levobunolol should be monitored carefully for hypertension. Withdraw Levobunolol several days before a gradual lowering of clonidine doses. Alternatively, substitute labetalol (an alpha/beta blocker) for clonidine.

    Diltiazem

  • Adverse Effect Hypotension, bradycardia, AV conduction disturbances
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure. A dosage adjustment for hepatically metabolized beta blockers may be required.

    Felodipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Flunarizine

  • Adverse Effect Hypotension, bradycardia, and AV conduction disturbances
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Flurbiprofen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ibuprofen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ibuprofen Comb.

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Indomethacin

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketoprofen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketorolac

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Lacidipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Lidoflazine

  • Adverse Effect Hypotension, bradycardia, and AV conduction disturbances
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Mefenamic Acid

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Meloxicam

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Methyldopa

  • Adverse Effect Exaggerated hypertensive response, tachycardia, or arrhythmias during physiologic stress or exposure to exogenous catecholamines
  • Clinical Management Monitor blood pressure carefully during concurrent therapy, especially during excessive physiologic stress or use of exogenous catecholamines such as phenylpropanolamine.

    Nabumetone

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Naproxen

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nifedipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nimesulide

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nitrendipine

  • Adverse Effect hypotension and/or bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Oxyphenbutazone

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol Comb.

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenacetin

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenylbutazone

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Piroxicam

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Prazosin - BPH

  • Adverse Effect An exaggerated hypotensive response to the first dose of the Prazosin - BPH
  • Clinical Management When concurrent therapy with Prazosin - BPH and Levobunolol is required, initiate Prazosin - BPH with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Ritodrine

  • Adverse Effect Potential interference with tocolytic action of ritodrine
  • Clinical Management It is possible to successfully treat a patient with both a beta blocker and a beta mimetic if an appropriate dosage is found and the clinical response is monitored.

    Tenoxicam

  • Adverse Effect Decreased antihypertensive effect
  • Clinical Management If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Terazosin - BPH

  • Adverse Effect An exaggerated hypotensive response to the first dose of Terazosin - BPH
  • Clinical Management When concurrent therapy with Terazosin - BPH and Levobunolol is required, initiate Terazosin - BPH with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Verapamil

  • Adverse Effect Hypotension, bradycardia
  • Clinical Management If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.
  • Lactulose
    Lamotrigine
    Levofloxacin Ophthalmic Solution
    Levothyroxine Sodium
    Lidocaine (Lignocaine)
    Liothyronine Sodium
    Lithium Carbonate
    Loperamide Hydrochloride
    Loratadine
    Lorazepam
    LMWH sodsalt
    Labetalol
    Lacidipine
    Lactobacillus
    L - asparaginase
    L-ornithine l-aspartate
    Lactobacillus Sporogenes - VU
    Lamivudine
    Lansoprazole
    Latanoprost
    Lefulnomide
    Leucoverin
    Leuprolide
    Levamisole
    Levobunolol
    Levocetrizine
    Levodopa
    Levofloxacin
    Levonorgestrel
    Lidoflazine
    Lignocaine LA
    Lincomycin
    Linezolid
    Liq Paraffin
    Lisinopril
    Lithium
    Lomefloxacin
    Lomustine
    Loperamide
    Losartan
    Lovastatin
    Loxapine
    Lynoestrenol
     
    Disclaimer